Publications by authors named "Kota Hira"

Article Synopsis
  • * In a case study of a Japanese girl with mosaic variegated aneuploidy syndrome, a known pathogenic variant was found using exome sequencing, but additional pathogenic variants were identified through RNA-seq and adaptive sampling techniques.
  • * The research demonstrated that RNA-seq can unveil transcriptomic abnormalities linked to pathological variants, showcasing the effectiveness of long-read sequencing in detecting complex genetic insertions.
View Article and Find Full Text PDF
Article Synopsis
  • - Gemcitabine and Docetaxel (GEM/DTX) are common chemotherapy drugs used for soft tissue sarcomas but their effectiveness against malignant rhabdoid tumors (MRTs) is not well-studied.
  • - In a small study, GEM/DTX was used as salvage therapy for relapsed MRTs, showing partial responses in 3 out of 4 patients, including two with malignant rhabdoid tumors of the kidney.
  • - While GEM/DTX shows potential for treating resistant MRTs, there are specific side effects that require careful monitoring, such as localized edema and pleural effusion.
View Article and Find Full Text PDF

Ponatinib is a third-generation tyrosine kinase inhibitor (TKI) reported to show a higher efficacy for adult Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL) than other TKIs. However, few studies describe ponatinib for pediatric Ph+ALL; therefore, the efficacy, safety, and optimal dosage have not been determined. Here, we report a 3-year-old girl with Ph+ALL treated by a ponatinib-containing regimen with therapeutic drug monitoring in the plasma and cerebrospinal fluid (CSF).

View Article and Find Full Text PDF